BID and colorectal carcinoma: We purposefully limited our clinical study design to test a single hypothesis that HIF-1 represses bid transcription leading to reduced Bid expression in ex vivo CRC having shown that hypoxia-driven downregulation of Bid occurred via a HIF-1-dependent pathway in CRC cell lines in vitro.